Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A population pharmacokinetic model for perioperative dosing of factor VIII in hemophilia A patients.
Hazendonk H, Fijnvandraat K, Lock J, Driessens M, van der Meer F, Meijer K, Kruip M, Gorkom BL, Peters M, de Wildt S, Leebeek F, Cnossen M, Mathôt R; “OPTI-CLOT” study group. Hazendonk H, et al. Among authors: kruip m. Haematologica. 2016 Oct;101(10):1159-1169. doi: 10.3324/haematol.2015.136275. Epub 2016 Jul 6. Haematologica. 2016. PMID: 27390359 Free PMC article.
Quantification of the relationship between desmopressin concentration and Von Willebrand factor in Von Willebrand disease type 1: A pharmacodynamic study.
Heijdra JM, Cloesmeijer ME, de Jager NCB, Leebeek FWG, Kruip MHJA, Cnossen MH, Mathôt RAA; OPTI-CLOT/ To WiN study group and SYMPHONY consortium. Heijdra JM, et al. Among authors: kruip mhja. Haemophilia. 2022 Sep;28(5):814-821. doi: 10.1111/hae.14582. Epub 2022 May 8. Haemophilia. 2022. PMID: 35526239
Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial.
Joosten LPT, van Doorn S, van de Ven PM, Köhlen BTG, Nierman MC, Koek HL, Hemels MEW, Huisman MV, Kruip M, Faber LM, Wiersma NM, Buding WF, Fijnheer R, Adriaansen HJ, Roes KC, Hoes AW, Rutten FH, Geersing GJ. Joosten LPT, et al. Among authors: kruip m. Circulation. 2024 Jan 23;149(4):279-289. doi: 10.1161/CIRCULATIONAHA.123.066485. Epub 2023 Aug 27. Circulation. 2024. PMID: 37634130 Free article. Clinical Trial.
Bleeding disorder of unknown cause: an illustrated review on current practice, knowledge gaps, and future perspectives.
Monard ALL, Mussert CMA, van Duijl TT, Kruip MJHA, Henskens YMC, van den Biggelaar M, Schutgens REG, Schols SEM, Fijnvandraat KJ, Meijer K, den Exter PL, Nieuwenhuizen L, van Moort I, Baker RI, O'Donnell JS, Cnossen MH, Heubel-Moenen FCJI. Monard ALL, et al. Among authors: kruip mjha. Res Pract Thromb Haemost. 2024 Nov 13;8(8):102625. doi: 10.1016/j.rpth.2024.102625. eCollection 2024 Nov. Res Pract Thromb Haemost. 2024. PMID: 39687924 Free PMC article.
Understanding European patterns of deprescribing antithrombotic medication during end-of-life care in patients with cancer.
Martens ESL, Becker D, Abele C, Abbel D, Achterberg WP, Bax JJ, Bertoletti L, Edwards ME, Font C, Gava A, Goedegebuur J, Højen AA, Huisman MV, Kruip MJHA, Mahé I, Mooijaart SP, Pearson M, Seddon K, Szmit S, Noble SIR, Klok FA, Konstantinides SV. Martens ESL, et al. Among authors: kruip mjha. Thromb Res. 2025 Jan;245:109205. doi: 10.1016/j.thromres.2024.109205. Epub 2024 Nov 9. Thromb Res. 2025. PMID: 39667100 Free article.
Functional characterization of a nanobody-based glycoprotein VI-specific platelet agonist.
Zivkovic M, Pols-van Veen E, van der Vegte V, Sebastian SAE, de Moor AS, Korporaal SJA, Schutgens REG, Urbanus RT; Thrombocytopathy in the Netherlands (TiN) study group; SYMPHONY consortium. Zivkovic M, et al. Res Pract Thromb Haemost. 2024 Oct 3;8(7):102582. doi: 10.1016/j.rpth.2024.102582. eCollection 2024 Oct. Res Pract Thromb Haemost. 2024. PMID: 39512585 Free PMC article.
Patient-reported data on the severity of Von Willebrand disease.
van Kwawegen CB, Fijnvandraat K, Kruip MJHA, de Meris J, Schols SEM, Meijer K, van der Bom JG, Cnossen MH, van Galen KPM, Atiq F, Eikenboom J, Leebeek FWG; WiN study group. van Kwawegen CB, et al. Among authors: kruip mjha. Haemophilia. 2024 Nov;30(6):1348-1356. doi: 10.1111/hae.15103. Epub 2024 Oct 15. Haemophilia. 2024. PMID: 39403864 Free PMC article.
Genetic variants, thrombocytopenia, and clinical phenotype of type 2B von Willebrand disease: a median 16-year follow-up study.
van Kwawegen CB, Atiq F, Endenburg D, Fijnvandraat K, van Galen KPM, Cnossen MH, Schols SEM, Kruip MJHA, van Heerde WL, de Meris J, van der Bom JG, Eikenboom J, Meijer K, Leebeek FWG; WiN study group. van Kwawegen CB, et al. Among authors: kruip mjha. J Thromb Haemost. 2024 Dec;22(12):3460-3472. doi: 10.1016/j.jtha.2024.08.028. Epub 2024 Sep 28. J Thromb Haemost. 2024. PMID: 39343102 Free article.
213 results